Defendant shall be punished by a fine of KRW 1,000,000.

If the defendant does not pay the above fine, 50,000 won.

Punishment of the crime

The defendant is the representative director of the D Co., Ltd. in Daejeon Dong-gu C and fourth.

1. No one shall indicate or advertise any content other than drugs or quasi-drugs which might lead to misunderstanding that they have medical efficacy, efficacy, etc., and shall sell, store or display for sale, items indicated or advertised similar to those of drugs;

Nevertheless, on October 201, the Defendant advertised that “E”, “F” products that were not permitted as non-pharmaceutical drugs, as having medical efficacy and effect, such as “ma”, “salivation and discontinuance,” and “salivation and discontinuance,” and “B” products, of which the Defendant had medical efficacy and effect.

2. No advertisement shall be made with respect to the efficacy or performance of a drug or quasi-pharmaceutical product, by making a false advertisement or exaggerated advertisement, and no advertisement shall be made by using an article, a photograph, a design, or any other secret means that suggest the efficacy or performance thereof;

Nevertheless, on October 201, the Defendant: (a) operated his own website from the mid-201 Police Officer; and (b) provided false and exaggerated advertisements by stating that there was the effect of “marbation prevention” and “marbation” other than “marb”, which is the efficacy and effect permitted for “G”, which is non-pharmaceutical drugs; and (c) offered a false description or an exaggerated advertisement by considering the product’s description of the increase in

Summary of Evidence

1. Partial statement of the defendant;

1. A protocol concerning the police interrogation of the accused;

1. Statement of the police statement related H;

1. Investigation report (report on the results of on-site investigations of I Burial Stops);

1. Investigation report (request for the collection and inspection of I products and quasi-drugs);

1. Investigation report (report on the result of inspection of I products and quasi-drugs);

1. Investigation report (checking the I head office (D) related to whether to provide the details of advertisement);

1. Investigation report (verification as to whether the permission for the medicine or quasi-drugs of “E” and “F” products is granted);

1. The investigation report [Attachment to reference materials relating to the difference between the “man” and the “man”] is applicable to the law.